A detailed history of Syon Capital LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Syon Capital LLC holds 894 shares of REGN stock, worth $638,736. This represents 0.08% of its overall portfolio holdings.

Number of Shares
894
Previous 902 0.89%
Holding current value
$638,736
Previous $948 Million 0.87%
% of portfolio
0.08%
Previous 0.09%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$1024.09 - $1201.76 $8,192 - $9,614
-8 Reduced 0.89%
894 $940 Million
Q2 2024

Aug 13, 2024

BUY
$883.2 - $1071.19 $11,481 - $13,925
13 Added 1.46%
902 $948 Million
Q1 2024

May 14, 2024

BUY
$902.69 - $993.35 $96,587 - $106,288
107 Added 13.68%
889 $856 Million
Q4 2023

Feb 02, 2024

BUY
$775.18 - $881.7 $130,230 - $148,125
168 Added 27.36%
782 $687 Million
Q3 2023

Nov 03, 2023

BUY
$692.45 - $844.37 $425,164 - $518,443
614 New
614 $505 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $76.6B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Syon Capital LLC Portfolio

Follow Syon Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Syon Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Syon Capital LLC with notifications on news.